Form 4: Laura Oliphant Trades AEHR Test Systems Stock
Insider Transaction Report
Laura Oliphant, a Director at AEHR Test Systems, reported a transaction involving the acquisition of 3,000 shares of common stock.
Summary
- Laura Oliphant, a Director at AEHR Test Systems, reported a transaction on April 9, 2026.
- She acquired 3,000 shares of common stock at a price of $68.3575 per share.
- Following this transaction, her beneficial ownership of common stock is 18,432 shares, which includes shares subject to unvested restricted stock units.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine insider transaction without providing new financial or strategic information.
Positives
- Director Laura Oliphant acquired additional shares, indicating potential confidence in the company's future.
- The acquisition of 3,000 shares at $68.3575 per share suggests a belief in the current valuation or undervaluation of the stock.
Future Outlook
This filing is a Form 4 reporting a stock transaction by an insider and does not contain forward-looking statements or guidance.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures of insider transactions and do not typically provide strategic insights. The transaction itself, an acquisition of shares by a director, can be interpreted as a positive signal by the market, though it is a single data point.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Laura Oliphant granted a Power of Attorney to specific individuals to execute and file Forms 3, 4, and 5 on her behalf. | 06/02/2023 | Facilitates timely and accurate reporting of insider transactions by authorized representatives. |
Stakeholder Impact
- Shareholders: May view the director's stock purchase as a positive signal of confidence in the company's prospects.
- Management: The transaction is a standard disclosure requirement, ensuring transparency.
Key Dates
| Date | Description |
|---|---|
| 06/02/2023 | Date of execution for the Power of Attorney granted by Laura Oliphant. |
| 04/09/2026 | Date of the reported stock transaction (acquisition of common stock). |
| 04/10/2026 | Date the Form 4 was signed by the attorney-in-fact. |
Keywords
AEHR Test Systems, Form 4, Insider Trading, Stock Transaction, Laura Oliphant, Director, Common Stock, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.